Event Agenda

• 1:30

  Welcome

  • 

    Mark B. McClellan

    Director, Engelberg Center for Health Care Reform

    Senior Fellow, Economic Studies

• 1:45

  Priorities for Biomedical Innovation in a Challenging Fiscal Environment

  • Ed Penhoet

    Director

    Alta Partners

  • 

    Mark B. McClellan

    Director, Engelberg Center for Health Care Reform

    Senior Fellow, Economic Studies

• 2:25

  Finding the Path Forward for Biomedical Innovation

  • Moderator

    

    Mark B. McClellan

    Director, Engelberg Center for Health Care Reform

    Senior Fellow, Economic Studies

  • Christopher Austin

    Director

    National Center for Advancing Translational Sciences

  • Deborah Brooks

    Co-Founder and Executive Vice Chairman

    The Michael J. Fox Foundation

  • Robert Conley

    Regulatory Leader and Distinguished Lilly Scholar

    Eli Lilly and Company

  • John Mendelsohn

    Professor, Department of Experimental Therapeutics, Division of Cancer Medicine and Director, Khalifa Institute for Personalized Cancer Therapy

    The University of Texas MD Anderson Cancer Center

  • Earl Steinberg

    Executive Vice President of Innovation & Dissemination

    Geisinger Health Solutions

• 3:20

  Closing Remarks

  • 

    Mark B. McClellan

    Director, Engelberg Center for Health Care Reform

    Senior Fellow, Economic Studies